Location History:
- Saint Julien En Genevois, FR (2012)
- Viry, FR (2015)
Company Filing History:
Years Active: 2012-2015
Title: Adeline Pretre: Innovator in Therapeutic Compounds
Introduction
Adeline Pretre is a pioneering inventor based in Viry, France, known for her significant contributions to the field of medicinal chemistry. With a focus on innovative compounds, she has developed novel treatments for various health conditions, earning her a reputation as a key figure in pharmaceutical research.
Latest Patents
Adeline Pretre holds two notable patents. The first patent involves indazolyl triazol derivatives, which are recognized for their potential use in the treatment of inflammation and autoimmune disorders. This innovative compound has opened new avenues for therapeutic interventions. The second patent pertains to phenoxyacetic acid derivatives, presenting a promising solution for CRTH2-related disorders, including asthma, atopic dermatitis, and other inflammatory dermatoses. These advancements highlight her dedication to improving health outcomes through science.
Career Highlights
Currently, Adeline Pretre is associated with Merck Serono S. A., a leading global biopharmaceutical company. Her role in the organization allows her to work at the forefront of drug discovery and development, contributing to the advancement of treatments for complex diseases. Her expertise in medicinal chemistry and commitment to research is evident in the impactful patents she has secured.
Collaborations
Throughout her career, Adeline has collaborated with esteemed colleagues, including Catherine Jorand-Lebrun and Stefano Crosignani. These partnerships have facilitated the exchange of ideas and fostered innovative research initiatives, further enhancing the development of her groundbreaking therapeutic compounds.
Conclusion
Adeline Pretre's work as an inventor has made substantial contributions to the field of healthcare. With her two patents focusing on innovative treatments for inflammation and autoimmune disorders, she exemplifies the impact of dedicated research and collaboration in advancing medical science. Her endeavors at Merck Serono S. A. continue to inspire future generations of inventors and scientists in the quest for novel therapeutic solutions.